Compare $IART vs $IRMD | Chartloom

Compare

$IART vs $IRMD

Integra Lifesciences Holdings Corp · IRadimed Corp

IART

Integra Lifesciences Holdings Corp

IRMD

IRadimed Corp

Compare $IART vs $IRMD

Comparing Integra Lifesciences Holdings Corp and IRadimed Corp

IARTIntegra Lifesciences Holdings Corp

IRMDIRadimed Corp

IARTIntegra Lifesciences Holdings Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

4.99x

Forward P/S (NTM)

0.60x

Rev growth (TTM)

0.8%

YTD performance

11.9%

52W performance

-9.3%

FCF yield

-1.4%

IRMDIRadimed Corp

Market cap

$1.12B

P/E (TTM)

48.83x

Forward P/E (NTM)

35.94x

Forward P/S (NTM)

10.91x

Rev growth (TTM)

11.2%

YTD performance

-8.4%

52W performance

13.8%

FCF yield

2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IART

IRMD

Detailed metrics comparison

IART

Integra Lifesciences Holdings Corp

IRMD

IRadimed Corp

Market Cap

IART$1.05B

IRMD$1.12B

Enterprise Value

IART$1.05B

IRMD$1.06B

Price

IART$13.44

IRMD$87.45

P/E Ratio

IARTN/A

IRMD48.83x

P/S Ratio

IART0.63x

IRMD12.94x

EV/Sales

IART0.63x

IRMD12.26x

EV/EBITDA

IART3.92x

IRMD36.27x

P/B Ratio

IART0.95x

IRMD10.73x

P/FCF Ratio

IARTN/A

IRMD45.53x

EV/FCF

IART-73.87x

IRMD43.12x

PEG Ratio

IARTN/A

IRMD4.03x

Forward P/E (NTM)

IART4.99x

IRMD35.94x

Forward P/S (NTM)

IART0.60x

IRMD10.91x

Revenue (TTM)

IART$1.66B

IRMD$86M

Revenue Growth (YoY)

IART0.8%

IRMD11.2%

Forward Rev Growth

IART3.2%

IRMD10.5%

Gross Margin (TTM)

IART43.1%

IRMD75.9%

Operating Margin (TTM)

IART4.0%

IRMD31.9%

EBITDA Margin (TTM)

IART16.1%

IRMD33.8%

Net Margin (TTM)

IART-0.1%

IRMD26.7%

FCF Margin (TTM)

IART-0.9%

IRMD28.4%

Net Income (TTM)

IART$-2M

IRMD$23M

FCF (TTM)

IART$-14M

IRMD$25M

EPS (TTM)

IART$0.00

IRMD$1.79

ROE (TTM)

IART-70.0%

IRMD23.4%

ROA (TTM)

IART-20.0%

IRMD20.4%

ROIC (TTM)

IART-25.0%

IRMD23.4%

Cash

IART$0

IRMD$59M

Debt

IART$0

IRMD$0

Net Cash/Debt

IART$0

IRMD$59M

Current Ratio (TTM)

IART3.60x

IRMD9.46x

Quick Ratio (TTM)

IART1.80x

IRMD7.89x

Debt/Equity (TTM)

IART1.79x

IRMD0.00x

Debt/Assets (TTM)

IART0.0%

IRMD0.0%

Interest Coverage (TTM)

IARTN/A

IRMDN/A

Net Debt/EBITDA (TTM)

IART0.00x

IRMD0.00x

Beta

IART1.27

IRMD0.94

52W Performance

IART-9.3%

IRMD13.8%

YTD Performance

IART11.9%

IRMD-8.4%

% from 52W High

IART-34.4%

IRMD-19.0%

% from 52W Low

IART54.5%

IRMD22.6%

Asset Turnover (TTM)

IART0.46x

IRMD0.76x

FCF Yield (TTM)

IART-1.4%

IRMD2.2%

Earnings Yield (TTM)

IART-0.2%

IRMD2.1%

Dividend Yield (TTM)

IARTN/A

IRMD1.4%

Rule of 40

IART-0.0

IRMD39.6

EV/GP/RG

IART0.26

IRMD0.86

Ticker research

View IART research View IRMD research

Metric	IART Integra Lifesciences Holdings Corp	IRMD IRadimed Corp
Market & Valuation
Market Cap	$1.05B	$1.12B
Enterprise Value	$1.05B	$1.06B
Price	$13.44	$87.45
P/E Ratio	N/A	48.83x
P/S Ratio	0.63x	12.94x
EV/Sales	0.63x	12.26x
EV/EBITDA	3.92x	36.27x
P/B Ratio	0.95x	10.73x
P/FCF Ratio	N/A	45.53x
EV/FCF	-73.87x	43.12x
PEG Ratio	N/A	4.03x
Forward P/E (NTM)	4.99x	35.94x
Forward P/S (NTM)	0.60x	10.91x
Revenue & Growth
Revenue (TTM)	$1.66B	$86M
Revenue Growth (YoY)	0.8%	11.2%
Forward Rev Growth	3.2%	10.5%
Profitability
Gross Margin (TTM)	43.1%	75.9%
Operating Margin (TTM)	4.0%	31.9%
EBITDA Margin (TTM)	16.1%	33.8%
Net Margin (TTM)	-0.1%	26.7%
FCF Margin (TTM)	-0.9%	28.4%
Net Income (TTM)	$-2M	$23M
FCF (TTM)	$-14M	$25M
EPS (TTM)	$0.00	$1.79
ROE (TTM)	-70.0%	23.4%
ROA (TTM)	-20.0%	20.4%
ROIC (TTM)	-25.0%	23.4%
Financial Health
Cash	$0	$59M
Debt	$0	$0
Net Cash/Debt	$0	$59M
Current Ratio (TTM)	3.60x	9.46x
Quick Ratio (TTM)	1.80x	7.89x
Debt/Equity (TTM)	1.79x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.27	0.94
52W Performance	-9.3%	13.8%
YTD Performance	11.9%	-8.4%
% from 52W High	-34.4%	-19.0%
% from 52W Low	54.5%	22.6%
Efficiency & Yields
Asset Turnover (TTM)	0.46x	0.76x
FCF Yield (TTM)	-1.4%	2.2%
Earnings Yield (TTM)	-0.2%	2.1%
Dividend Yield (TTM)	N/A	1.4%
Other
Rule of 40	-0.0	39.6
EV/GP/RG	0.26	0.86
Ticker research	View IART research	View IRMD research

Valuation

P/E Ratio

IRMD

48.83x

P/S Ratio

IART

0.63x

IRMD

12.94x

EV/FCF

IART

-73.87x

IRMD

43.12x

Growth & revenue

Revenue Growth TTM

IRMD

11.2%

IART

0.8%

Forward Revenue Growth

IRMD

10.5%

IART

3.2%

Profitability & performance

Gross Margin

IRMD

75.9%

IART

43.1%

ROE

IRMD

23.4%

IART

-70.0%

FCF Yield %

IRMD

2.2%

IART

-1.4%

52-Week Performance

IRMD

13.8%

IART

-9.3%

Detailed metrics comparison

IART

Integra Lifesciences Holdings Corp

IRMD

IRadimed Corp

Market Cap

IART$1.05B

IRMD$1.12B

Enterprise Value

IART$1.05B

IRMD$1.06B

Price

IART$13.44

IRMD$87.45

P/E Ratio

IARTN/A

IRMD48.83x

P/S Ratio

IART0.63x

IRMD12.94x

EV/Sales

IART0.63x

IRMD12.26x

EV/EBITDA

IART3.92x

IRMD36.27x

P/B Ratio

IART0.95x

IRMD10.73x

P/FCF Ratio

IARTN/A

IRMD45.53x

EV/FCF

IART-73.87x

IRMD43.12x

PEG Ratio

IARTN/A

IRMD4.03x

Forward P/E (NTM)

IART4.99x

IRMD35.94x

Forward P/S (NTM)

IART0.60x

IRMD10.91x

Revenue (TTM)

IART$1.66B

IRMD$86M

Revenue Growth (YoY)

IART0.8%

IRMD11.2%

Forward Rev Growth

IART3.2%

IRMD10.5%

Gross Margin (TTM)

IART43.1%

IRMD75.9%

Operating Margin (TTM)

IART4.0%

IRMD31.9%

EBITDA Margin (TTM)

IART16.1%

IRMD33.8%

Net Margin (TTM)

IART-0.1%

IRMD26.7%

FCF Margin (TTM)

IART-0.9%

IRMD28.4%

Net Income (TTM)

IART$-2M

IRMD$23M

FCF (TTM)

IART$-14M

IRMD$25M

EPS (TTM)

IART$0.00

IRMD$1.79

ROE (TTM)

IART-70.0%

IRMD23.4%

ROA (TTM)

IART-20.0%

IRMD20.4%

ROIC (TTM)

IART-25.0%

IRMD23.4%

Cash

IART$0

IRMD$59M

Debt

IART$0

IRMD$0

Net Cash/Debt

IART$0

IRMD$59M

Current Ratio (TTM)

IART3.60x

IRMD9.46x

Quick Ratio (TTM)

IART1.80x

IRMD7.89x

Debt/Equity (TTM)

IART1.79x

IRMD0.00x

Debt/Assets (TTM)

IART0.0%

IRMD0.0%

Interest Coverage (TTM)

IARTN/A

IRMDN/A

Net Debt/EBITDA (TTM)

IART0.00x

IRMD0.00x

Beta

IART1.27

IRMD0.94

52W Performance

IART-9.3%

IRMD13.8%

YTD Performance

IART11.9%

IRMD-8.4%

% from 52W High

IART-34.4%

IRMD-19.0%

% from 52W Low

IART54.5%

IRMD22.6%

Asset Turnover (TTM)

IART0.46x

IRMD0.76x

FCF Yield (TTM)

IART-1.4%

IRMD2.2%

Earnings Yield (TTM)

IART-0.2%

IRMD2.1%

Dividend Yield (TTM)

IARTN/A

IRMD1.4%

Rule of 40

IART-0.0

IRMD39.6

EV/GP/RG

IART0.26

IRMD0.86

Ticker research

View IART research View IRMD research

Metric	IART Integra Lifesciences Holdings Corp	IRMD IRadimed Corp
Market & Valuation
Market Cap	$1.05B	$1.12B
Enterprise Value	$1.05B	$1.06B
Price	$13.44	$87.45
P/E Ratio	N/A	48.83x
P/S Ratio	0.63x	12.94x
EV/Sales	0.63x	12.26x
EV/EBITDA	3.92x	36.27x
P/B Ratio	0.95x	10.73x
P/FCF Ratio	N/A	45.53x
EV/FCF	-73.87x	43.12x
PEG Ratio	N/A	4.03x
Forward P/E (NTM)	4.99x	35.94x
Forward P/S (NTM)	0.60x	10.91x
Revenue & Growth
Revenue (TTM)	$1.66B	$86M
Revenue Growth (YoY)	0.8%	11.2%
Forward Rev Growth	3.2%	10.5%
Profitability
Gross Margin (TTM)	43.1%	75.9%
Operating Margin (TTM)	4.0%	31.9%
EBITDA Margin (TTM)	16.1%	33.8%
Net Margin (TTM)	-0.1%	26.7%
FCF Margin (TTM)	-0.9%	28.4%
Net Income (TTM)	$-2M	$23M
FCF (TTM)	$-14M	$25M
EPS (TTM)	$0.00	$1.79
ROE (TTM)	-70.0%	23.4%
ROA (TTM)	-20.0%	20.4%
ROIC (TTM)	-25.0%	23.4%
Financial Health
Cash	$0	$59M
Debt	$0	$0
Net Cash/Debt	$0	$59M
Current Ratio (TTM)	3.60x	9.46x
Quick Ratio (TTM)	1.80x	7.89x
Debt/Equity (TTM)	1.79x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.27	0.94
52W Performance	-9.3%	13.8%
YTD Performance	11.9%	-8.4%
% from 52W High	-34.4%	-19.0%
% from 52W Low	54.5%	22.6%
Efficiency & Yields
Asset Turnover (TTM)	0.46x	0.76x
FCF Yield (TTM)	-1.4%	2.2%
Earnings Yield (TTM)	-0.2%	2.1%
Dividend Yield (TTM)	N/A	1.4%
Other
Rule of 40	-0.0	39.6
EV/GP/RG	0.26	0.86
Ticker research	View IART research	View IRMD research